Literature DB >> 631883

Enhancement of experimental anaerobic infections by blood, hemoglobin, and hemostatic agents.

G B Hill.   

Abstract

Certain foreign materials have been demonstrated to enhance the infectivity of aerobic and anaerobic bacteria. Whole blood and other protein compounds encountered in surgical settings or trauma were tested for their effect on infectivity of nonsporeforming anaerobic bacteria. Infectious synergistic mixtures of Bacteroides fragilis plus Peptostreptococcus anaerobius and Bacteroides melaninogenicus plus Fusobacterium necrophorum were each diluted to a barely noninfectious or minimally infectious concentration (subinfective inoculum) that was injected intraperitoneally into mice alone and in combination with test proteins. Infectivity was measured by deaths from sepsis or abscess(es) within the abdominal cavity at autopsy at 1 week. Two hemostatic agents, Gelfoam powder and Avitene (final concentrations, 10 mg/ml), and crystalline hemoglobin (4 g/100 ml) each produced a marked increase (P < 0.001) in the rate of infection when mixed with a normally subinfective inoculum of either bacterial mixture. Fresh homologous mouse blood (0.25 ml) injected intraperitoneally without anticoagulant also significantly enhanced infectivity (P < 0.01) of a subinfective inoculum of B. fragilis plus P. anaerobius. These studies demonstrated the capacity of whole blood, hemoglobin, and hemostatic agents to enhance the infectivity of certain nonsporeforming anaerobic bacteria. The high concentrations of anaerobic bacteria in the gastrointestinal, female genital, and respiratory tracts produce an increased risk of human infection after surgery or trauma in these sites; the protein agents studied here may further enhance infection.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 631883      PMCID: PMC414103          DOI: 10.1128/iai.19.2.443-449.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  A possible toxic factor in abdominal injury.

Authors:  J H DAVIS; A B YULL
Journal:  J Trauma       Date:  1962-05

2.  The red blood cell: an essential component of the toxicity of strangulation intestinal obstruction.

Authors:  J H DAVIS; A B YULL
Journal:  Proc Soc Exp Biol Med       Date:  1961-10

3.  Studies on synergistic infections. I. Experimental infections with anaerobic streptococci.

Authors:  S E MERGENHAGEN; J C THONARD; H W SCHERP
Journal:  J Infect Dis       Date:  1958 Jul-Aug       Impact factor: 5.226

4.  Complications from the use of absorbable hemostatic sponges.

Authors:  P A LINDSTROM
Journal:  AMA Arch Surg       Date:  1956-07

5.  Effect of gelfoam on the integrity of intestinal anastomosis.

Authors:  B E CHAMBERLAIN; J E DELMONICO; R O GREGG
Journal:  Am J Surg       Date:  1951-10       Impact factor: 2.565

6.  Chemotherapy of an experimental Fusobacterium (Sphaerophorus) necrophorum infection in mice.

Authors:  T D Wilkins; L D Smith
Journal:  Antimicrob Agents Chemother       Date:  1974-06       Impact factor: 5.191

7.  Staphylococcus aureus bacteremia; report of a case with cure by combined antibiotic therapy and surgical eradication of an unusual focus of infection.

Authors:  S C KRAVITZ; C N BREED
Journal:  J Am Med Assoc       Date:  1951-03-17

8.  Mechanisms of the adjuvant action of hemoglobin in experimental peritonitis. 2. Influence of hemoglobin on human leukocyte chemotaxis in vitro.

Authors:  T Hau; R D Nelson; V D Fiegel; R Levenson; R L Simmons
Journal:  J Surg Res       Date:  1977-03       Impact factor: 2.192

Review 9.  The role of iron in host resistance.

Authors:  H A Pearson; J E Robinson
Journal:  Adv Pediatr       Date:  1976

10.  Therapeutic evaluation of minocycline and tetracycline for mixed anaerobic infection in mice.

Authors:  G B Hill
Journal:  Antimicrob Agents Chemother       Date:  1977-04       Impact factor: 5.191

View more
  8 in total

Review 1.  Clinical benefits and risk analysis of topical hemostats: a review.

Authors:  Yasuko Tomizawa
Journal:  J Artif Organs       Date:  2005       Impact factor: 1.731

2.  [Prevention of pocket-related complications following heart rhythm device implantation. D-Stat Hemostat™ versus vacuum drainage].

Authors:  Marc-Alexander Ohlow; Björn Buchter; Michele Brunelli; Bernward Lauer; Matthias Schreiber; J Christoph Geller
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2015-02-03

3.  Host response to mixed anaerobic infection with Bacteroides melaninogenicus and Fusobacterium necrophorum.

Authors:  R E McCallum; R Urbaschek; B Ditter; B Urbaschek
Journal:  Infection       Date:  1983 Jan-Feb       Impact factor: 3.553

4.  Heme drives hemolysis-induced susceptibility to infection via disruption of phagocyte functions.

Authors:  Rui Martins; Julia Maier; Anna-Dorothea Gorki; Kilian V M Huber; Omar Sharif; Philipp Starkl; Simona Saluzzo; Federica Quattrone; Riem Gawish; Karin Lakovits; Michael C Aichinger; Branka Radic-Sarikas; Charles-Hugues Lardeau; Anastasiya Hladik; Ana Korosec; Markus Brown; Kari Vaahtomeri; Michelle Duggan; Dontscho Kerjaschki; Harald Esterbauer; Jacques Colinge; Stephanie C Eisenbarth; Thomas Decker; Keiryn L Bennett; Stefan Kubicek; Michael Sixt; Giulio Superti-Furga; Sylvia Knapp
Journal:  Nat Immunol       Date:  2016-10-31       Impact factor: 25.606

5.  Lethal Haemophilus influenzae type b infection in mice.

Authors:  M I Marks; E J Ziegler; H Douglas; L B Corbeil
Journal:  Infection       Date:  1982 Sep-Oct       Impact factor: 3.553

6.  Animal model for anaerobic lung abscess.

Authors:  D W Kannangara; H Thadepalli; V T Bach; D Webb
Journal:  Infect Immun       Date:  1981-02       Impact factor: 3.441

7.  A quantitative model for subcutaneous abscess formation in mice.

Authors:  K A Joiner; A B Onderdonk; J A Gelfand; J G Bartlett; S L Gorbach
Journal:  Br J Exp Pathol       Date:  1980-02

8.  Surgicel® (oxidized regenerated cellulose) granuloma mimicking local recurrent gastrointestinal stromal tumor: A case report.

Authors:  Hao Wang; Ping Chen
Journal:  Oncol Lett       Date:  2013-02-28       Impact factor: 2.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.